NewswireToday - /newswire/ - Washington, DC, United States, 04/17/2007 - Past advertisers include: Novartis, Sepracor, Merck, PDI Inc., Pfizer, Schering-Plough, Innovex, Eli Lilly, Boehringer Ingelheim, Andrx Laboratories, BIOGEN, Sanofi-Aventis, PD Labs plus many more.

Novo Nordisk joins a long list of pharmaceutical companies who have supported the NAPSRx® when they look to add to their sales force. (Past advertisers include: Novartis, Sepracor, Merck, PDI Inc., Pfizer, Schering-Plough, Innovex, Eli Lilly, Boehringer Ingelheim, Andrx Laboratories, BIOGEN, Sanofi-Aventis, PD Labs plus many more) If your company needs help in recruiting, education, or training please email the association.

Diabetes Care Specialists positions are available at Novo Nordisk. Each sales rep will implement national NN sales strategies on a local level. They sell mainly upon primary care physicians and are focused on improving the standard of care for diabetes by providing better methods of prevention, detection and treatment.

Novo Nordisk uses recombinant DNA technology to make innovative products for people with diabetes. They first marketed insulin for commercial use in 1923, and today they offer a comprehensive line of human insulin and insulin analog products. Novo Nordisk created the world's first insulin pen device, and now they are a world leader in production and distribution of these revolutionary insulin delivery systems.

The NAPSRx® has been highly recommended to the many individuals who are looking to break into the Pharmaceutical Sales industry as well as for advancing the careers of current pharmaceutical reps. If you are looking to gain entry into the industry, please review the areas of the website geared to entry-level sales.

Agency / Source: NAPSR

Availability: All Regions (Including Int'l)

Traffic Booster: [/] Quick Newswire Today Visibility Checker

Distribution: [+] Free Press Release & Newswire Distribution Network. via PRZOOM - Newswire Today (NewswireToday.com)